The estimated Net Worth of Paul Treacy is at least $3.97 Million dollars as of 12 August 2019. Paul Treacy owns over 4,371 units of Jazz Pharmaceuticals plc stock worth over $1,726,024 and over the last 10 years Paul sold JAZZ stock worth over $2,242,681.
Paul has made over 12 trades of the Jazz Pharmaceuticals plc stock since 2015, according to the Form 4 filled with the SEC. Most recently Paul sold 4,371 units of JAZZ stock worth $600,575 on 12 August 2019.
The largest trade Paul's ever made was selling 4,371 units of Jazz Pharmaceuticals plc stock on 12 August 2019 worth over $600,575. On average, Paul trades about 971 units every 91 days since 2014. As of 12 August 2019 Paul still owns at least 16,418 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Paul Treacy stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, L2, .
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright, and Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: